Voice analysis platform Sonde Health raises $19.25M (MobiWell beingInformation):
AI-enabled voice technology platkind Sonde Well being introduced it raised $19.25 million in a Sequence B funding spherical led by Halfners Make investmentsment, carrying its whole increase to $35.25 million … Sonde Well being makes use of patented voice technology to detect various well being conditions from biomarkers in a person’s voice, including analyzing respiratory matchness and detecting depression and nervousness.
The funding will assist construct out the company’s technology to detect additional well being conditions, develop its curhire respiratory and malestal health-monitoring technologies, and drive global commercial progress.
“Digital biomarkers are becoming a majorkeep in well beingcare. In the present day’s well beingcare companies are actualizing how vocal biomarkers can interact people earlier of their well being. The info and insights present in voice can power well being monitoring and affected person stratification so points can turn into apparent nicely earlier than a valuely medical occasion happens,” David Liu, CEO of Sonde Well being, mentioned in a statement. “With voice and any listening machine, accessible and effective well being monitoring might be made availcapable of the keyity of the world.”
Sonde Well being, a well being technology company committed to carrying accessible well being monitoring to eachone, has raised a $19.25 million Sequence B make investmentsment spherical … The company has raised $35.25 million in whole and can use the funding to drive its global commercial progress, deepen its respiratory and malestal well being monitoring technologies, and construct capabilities for additional well being circumstances.
Sonde licenses its platkind to customers globally in two methods:
Well being Checks
- Respiratory Matchness: Sonde’s platkind can detect and monitor respiratory well being conditions, like asthma, from 6 seconds of voice. Sufferers are engaging with Sonde’s respiratory matchness well being checks 2+ occasions per week.
- Malestal Matchness: Sonde’s platkind can detect and monitor evidence of depression and anxiety from 30 seconds of voice. Sufferers are engaging with Sonde’s malestal matchness well being checks 3+ occasions per week.
Vocal Biomarker Growth
- MCI, COPD, General Well being: Sonde is developing novel vocal biomarkers utilizing its professionalprietary “research-build-validation” methodologyology with clinical companions.
… GN Group will integrate Sonde’s Malestal Matchness vocal biomarker into its hearing products. The company is already working with Sonde to develop an MCI vocal biomarker. Qualcomm, which has already integrated Sonde’s vocal biomarkers into its cellular machine chipsets, has prolonged the relationship to incorporate its put onin a position chipsets. Koye Pharmaceuticals, which had already engaged Sonde to develop a COPD vocal biomarker, has developed the halfnership to develop a novel malestal well being vocal biomarker for deployment in India.